Savarez, Baby Boy .
HRN: 24-32-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/25/2024
03/03/2024
IV
45mg
Q24
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes